A vial containing the Moderna COVID-19 vaccine is seen at a temporary vaccination center of Swiss Medix health center as the spread of the coronavirus disease continues, in the Offene St. Jakob Kirche Reformed church in Zurich, Switzerland May 12, 2021. REUTERS/Arnd Wiegmann
Shares in South Korean drug contract manufacturer Samsung BioLogics (207940.KS) rose as much as 5.2% in early Monday trade, after it agreed to fill-finish manufacture Moderna's (MRNA.O) COVID-19 vaccine.
The agreement was part of Moderna Inc and Novavax Inc (NVAX.O) entering into a deal with the South Korean government to manufacture their COVID-19 vaccines. read more
The wider market (.KS11) was down 0.2% as of 0007 GMT.
Our Standards: The Thomson Reuters Trust Principles.
"make" - Google News
May 24, 2021 at 07:16AM
https://ift.tt/3fgbKw0
Samsung BioLogics shares rise after agrees to make Moderna COVID-19 vaccine - Reuters
"make" - Google News
https://ift.tt/2WG7dIG
https://ift.tt/2z10xgv
Bagikan Berita Ini
0 Response to "Samsung BioLogics shares rise after agrees to make Moderna COVID-19 vaccine - Reuters"
Post a Comment